- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06877793
Indocyanine Green (ICG) 운동 모델링을 사용한 생명을 위협하는 괴사 연조직 감염 (NSTI)의 실시간 진단
Necrotizing soft-tissue infections (NSTIs, a.k.a. "necrotizing fasciitis" or "flesh-eating bacteria") are aggressive infections that can progress rapidly from mild symptoms to sepsis, multi-organ failure, and death. NSTI cases present with non-specific clinical, imaging, and laboratory findings, and standard-of-care techniques for NSTI diagnosis lack sensitivity and specificity, resulting in frequent misdiagnosis and delayed care, which is the single most important predictor of survival. Consequently, the cumulative mortality rate for patients with NSTIs is 20- 30%; a dire need exists for more accurate and rapid detection of NSTIs. Fluorescence-guided surgery is a nascent technology seeking to improve the recognition of anatomical structures and disease processes using fluorescent probes (fluorophores). Indocyanine green (ICG) is an FDA-approved, near-infrared fluorophore with a >60-year safety record for vascular perfusion assessment. A distinguishing histological feature of NSTIs is prominent blood vessel thrombosis in affected tissues. Leveraging these pro-thrombotic effects, our study group has demonstrated in a first-in-human study (NCT04839302) that intravenous administration of ICG and immediate fluorescence imaging reveals prominent signal deficits in NSTI-positive tissues that differentiate significantly with increased signal seen with more common-and less virulent-infections such as cellulitis. We seek now to evaluate this imaging technique on a broader scale and determine if our findings are consistent for patients affected by NSTI-causing pathogens that are not endemic to our region. This prospective, observational, multicenter clinical study will involve video-rate ICG fluorescence imaging of patients suspected of having NSTIs who present to eight tertiary, Level 1 medical centers across the United States (Aim 1). Using dynamic contrast-enhanced fluorescence imaging (DCE-FI), time profiles of ICG fluorescence intensity from different tissue pixels/regions will be extracted and parameterized to extract first-pass kinetic features. These DCE-FI features, which characterize tissue perfusion, will be evaluated alone and in combination with anonymized electronic medical record data to create a DCE-FI-based clinical decision tool and a machine- learning-based fusion (DCE FI+lab/imaging data) tool; these will be compared to identify the most accurate means of diagnosing NSTIs (Aim 2). The best-performing tool will then be evaluated-compared to current diagnostic tests-in a prospective observational clinical study of patients presenting to tertiary emergency departments with findings concerning for NSTIs (Aim 3). Based on our human study, fluorescence imaging will not delay current standard of care. To ensure data fidelity, all sites will use similar: 1) commercial fluorescence imaging systems and accessories; and 2) validated commercial fluorescence reference phantoms. Based on our early results, we have strong confidence that following rigorous testing, ICG DCE-FI will lead to an entirely new methodology for rapid identification of patients with NSTIs, which will ultimately reduce patient morbidity and improve survival.
연구 개요
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Eric R Henderson, MD
- 전화번호: 603-650-5133
- 이메일: Eric.R.Henderson@hitchcock.org
연구 연락처 백업
- 이름: Morgan T Mazanec, MPH
- 전화번호: 603-308-9233
- 이메일: Morgan.T.Mazanec@Hitchcock.ORG
연구 장소
-
-
California
-
Los Angeles, California, 미국, 90095
- 모병
- University of California, Los Angeles
-
수석 연구원:
- Christopher Lee, MD
-
연락하다:
- Christopher Lee, MD
- 전화번호: 310-319-1234
- 이메일: ChristopherLee@mednet.ucla.edu
-
부수사관:
- Nicholas Bernthal, MD
-
Stanford, California, 미국, 94305
- 모병
- Stanford University
-
수석 연구원:
- Joseph Forrester, MD
-
연락하다:
- Joseph Forrester, MD
- 이메일: jdf1@stanford.edu
-
부수사관:
- Ariel Knight, MD
-
-
Georgia
-
Atlanta, Georgia, 미국, 30322
- 모병
- Emory University/Grady Memorial Hospital
-
연락하다:
- Morgan Fuller
- 전화번호: (404) 251-8953
- 이메일: jaimo.ahn@emory.edu
-
수석 연구원:
- Jaimo Ahn, MD, PhD
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48104
- 모병
- University of Michigan
-
연락하다:
- Molly Hunter, MD
- 이메일: huntmary@med.umich.edu
-
수석 연구원:
- Molly Hunter, MD
-
수석 연구원:
- Raymond Jean, MD
-
-
New Hampshire
-
Lebanon, New Hampshire, 미국, 03756
- 모병
- Dartmouth-Hitchcock Medical Center
-
연락하다:
- Eric R Henderson, MD
- 전화번호: 603-650-5133
- 이메일: Eric.R.Henderson@hitchcock.org
-
부수사관:
- Jonathan Elliot, PhD
-
부수사관:
- Samuel S Streeter, PhD
-
부수사관:
- Macgregor Montano, PharmD
-
부수사관:
- Scott Rodi, MD
-
수석 연구원:
- Eric R Henderson, MD
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, 미국, 19104
- 모병
- University of Pennsylvania
-
연락하다:
- Niels Martin, MD, PhD
- 이메일: Niels.Martin@pennmedicine.upenn.edu
-
수석 연구원:
- Niels Martin, MD, PhD
-
부수사관:
- Sunil Singhal, MD, PhD
-
부수사관:
- Jane Keating, MD
-
Pittsburgh, Pennsylvania, 미국, 15213
- 모병
- University of Pittsburgh Medical Center
-
연락하다:
- Kurt Weiss, MD
- 전화번호: (412) 802-4137
- 이메일: weiskr@UPMC.EDU
-
수석 연구원:
- Kurt Weiss, MD
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37235
- 모병
- Vanderbilt University
-
연락하다:
- Jonathan Schoenecker, MD, PhD
- 전화번호: (615) 936-3391
- 이메일: jon.schoenecker@vumc.org
-
수석 연구원:
- Jonathan Schoenecker, MD, PhD
-
부수사관:
- William Obremskey, MD
-
부수사관:
- Eben Rosenthal, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Patients presenting to the ED or clinic who are considered at intermediate- or high-risk for NSTI.
설명
Inclusion Criteria:
- Age ≥18 years.
- Clinical suspicion of NSTI based on the local standard of care warranting:
- Hospital admission for observation due to suspected NSTI; and/or
- Soft tissue biopsy to rule in/out suspected NSTI; and/or
- Surgical debridement for suspected NSTI; and/or
- Specific institutional threshold criteria for triggering NSTI work-up; and
- Ability to give written informed consent.
Exclusion Criteria:
- History of allergy to ICG and/or iodine.
- Pregnant women or nursing mothers.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: PROSPECTIVE
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Determine if tissue perfusion, determined by first-pass ICG fluorescence kinetics, is reliably reduced in the setting of a necrotizing infection compared to a non-necrotizing infection.
기간: From enrollment to the end of fluorescence imaging (about 1 day)
|
We will evaluate first-pass fluorescence signal intensity changes from indocyanine green (ICG), a vascular perfusion fluorophore, in the setting of severe soft-tissue infections to determine if ICG fluorescence may be an accurate and reliable diagnostic test for differentiating life-threatening necrotizing infections from non-life-threatening non-necrotizing infections. |
From enrollment to the end of fluorescence imaging (about 1 day)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Determine if first-pass ICG fluorescence kinetics in patients with necrotizing infections vary based on the causative bacterial species.
기간: From enrollment to the end of imaging and lab results (about 30 days)
|
In patients who had a documented necrotizing soft-tissue infection, we will compare first-pass fluorescence signal intensity changes from ICG based on the predominant causative bacterial species isolated from a patient's infection to determine if ICG signal changes vary by species. |
From enrollment to the end of imaging and lab results (about 30 days)
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .